A survey to determine prostate cancer-related knowledge, beliefs, and prior screening behavior was administered to men participating in prostate cancer screening events at nine major sites in the southeast.
Since prostate cancer disproportionately affects blacks, a primary focus of the analysis was to determine if differences in responses exist between racial groups.
A 20-question, multiple-choice survey to ascertain prostate cancer knowledge and beliefs, demographics, and health care access information was administered at nine major southeastern sites.
Major findings of this study on 286 black and 1218 white men are as follows :
(1) only 28% of black or white men report that their doctor ever discussed a test for prostate cancer with them ;
(2) blacks were less likely to have a regular doctor (P=0.03) or ever to have had a digital rectal examination (P<0.001) or prostate-specific antigen testing (P=0.005) ;
(3) blacks were less likely to report knowing someone with prostate cancer (P<0.001) and were more apt to report their acquaintances experiencing post-treatment impotence than whites (P=0.03) ;
(4) a substantial number of all men did not know that race and/or heredity are risk factors.
Important differences, however, in access to screening, perception of the disease and its treatment, and knowledge of risk factors exist between racial groups and represent significant barriers to early detection among African Americans.
Mots-clés Pascal : Epithélioma, Prostate, Comportement, Education sanitaire, Etats Unis, Amérique du Nord, Amérique, Exploration, Facteur risque, Dépistage, Adulte, Homme, Mâle, Race, Etude comparative, Négroïde, Mongoloïde, Appareil urinaire pathologie, Appareil génital mâle pathologie, Prostate pathologie, Tumeur maligne
Mots-clés Pascal anglais : Carcinoma, Prostate, Behavior, Health education, United States, North America, America, Exploration, Risk factor, Medical screening, Adult, Human, Male, Race, Comparative study, Negroid, Mongoloid, Urinary system disease, Male genital diseases, Prostate disease, Malignant tumor
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0529886
Code Inist : 002B14D02. Création : 01/03/1996.